|7.75||-0.34 / -4.20%|
Data as of 3:59pm ET
|7.69||-0.06 / -0.77%|
The 5 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 7.50. The median estimate represents a +93.55% increase from the last price of 7.75.
The current consensus among 5 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.